Biomet Pays $22 Million In Latest Medical Device Bribery Settlement (Wall Street Journal)
Orthopedic manufacturer Biomet Inc. agreed to pay more than $22 million in penalties Monday to settle charges that it violated a U.S. anti-bribery law.
The settlement stems from an industry-wide probe into a group of medical device companies conducted by the Department of Justice and Securities and Exchange Commission. The investigation, which is examining potential violations of the Foreign Corrupt Practices Act, has already netted more than $90 million in sanctions.
The FCPA, a 1977 law, prohibits impro...
The Orthopedics Industry 
